Dallah Healthcare Company

Equities

4004

SA135G51UI10

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E. Other stock markets 13:20:04 04/07/2024 BST			5-day change	1st Jan Change
156 ^SAR	+0.65%		-1.89%	-9.20%

07-03	Goldman Sachs Lifts Dallah Healthcare PT, Keeps at Neutral	MT
07-02	Saudi Shares Close in the Red; Dallah Healthcare Plans SAR1.2 Billion Property Fund	MT

Healthcare Co. Announces Signing Memorandum of Understanding with Dallah Real Estate Company, Tatweer Company, and Aljazira Capital

July 02, 2024 at 05:30 am

Dallah Healthcare Co. announced signing a Memorandum of Understanding with Dallah Real Estate Company, Tatweer Company, and Aljazira Capital. The Company announces the signing of a non-binding MoU with: Aljazira Capital Company ("Aljazira Capital"), Dallah Real Estate Company ("Dallah Real Estate"), Tatweer Company (''Tatweer'').

Latest news about Dallah Healthcare Company

Goldman Sachs Lifts Dallah Healthcare PT, Keeps at Neutral	07-03	MT
Saudi Shares Close in the Red; Dallah Healthcare Plans SAR1.2 Billion Property Fund	07-02	MT
Dallah Healthcare Signs MoU for SAR1.2 Billion Real Estate Fund	07-02	MT
Healthcare Co. Announces Signing Memorandum of Understanding with Dallah Real Estate Company, Tatweer Company, and Aljazira Capital	07-02	CI
Tadawul Welcome New Trading Week in Red; Saudi's Q1 Unemployment Rate Comes in at 3.5%	06-30	MT
Dallah Healthcare Signs SAR690 Million Construction Contract for Hospital in Saudi Arabia	06-30	MT
Dallah Healthcare Maintains Q1 Dividend	06-12	MT
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Dallah Healthcare Posts Higher Q1 Net Profit, Revenue	05-13	MT
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Dallah Healthcare Logs Higher FY23 Net Profit, Revenue	03-14	MT
Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare	03-05	MT
Dallah Healthcare Company signed of a non-binding memorandum agreement to acquire 97% stake in Al-Ahsa Medical Services Company and 100% stake in Al-Salam Medical Services Company from Ayyan Investment Company.	02-25	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for the Fourth Quarter of 2023, Payable on 30 January 2024	12-26	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/08/23	CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23/05/23	CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23	CI
Dallah Healthcare Company completed the acquisition of an additional 18.98% stake in International Medical Centre.	15/01/23	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for Second Half of the Fiscal Year 2022, Payable on December 29, 2022	19/12/22	CI
Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee	16/11/22	CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Dallah Healthcare Company Approves Board Appointments	02/11/22	CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2022	21/09/22	CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/08/22	CI

Chart Dallah Healthcare Company

Duration

Period

More charts

Company Profile

Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitalsâ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicinesâ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Officeâs segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.

Sector

Healthcare Facilities & Services

Calendar

05/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Dallah Healthcare Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

156 SAR

Average target price

156.6 SAR

Spread / Average Target

+0.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
DALLAH HEALTHCARE COMPANY	-9.20%	4.04B
AIER EYE HOSPITAL GROUP CO., LTD.	-36.66%	13.17B
IHH HEALTHCARE	+4.98%	11.81B
BANGKOK DUSIT MEDICAL SERVICES	-4.50%	11.28B
APOLLO HOSPITALS ENTERPRISE LIMITED	+9.13%	10.67B
THE ENSIGN GROUP, INC.	+12.65%	7.14B
RAMSAY HEALTH CARE LIMITED	-10.61%	7.13B
MOUWASAT MEDICAL SERVICES COMPANY	+9.12%	6.5B
FORTIS HEALTHCARE LIMITED	+12.27%	4.25B
GLOBAL HEALTH LIMITED	+32.50%	4.09B

Hospitals, Clinics & Primary Care Services